Cancer Incidence and Mortality among Non-Hispanic Blacks, Westchester County, 2006-2010
Source: New York State Cancer Registry
| Site of Cancer | Incidence | Mortality | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Males | Females | Males | Females | |||||||||
| Average Annual Cases | Rate per 100,000 Males | 95% CI (+/-) | Average Annual Cases | Rate per 100,000 Females | 95% CI (+/-) | Average Annual Deaths | Rate per 100,000 Males | 95% CI (+/-) | Average Annual Deaths | Rate per 100,000 Females | 95% CI (+/-) | |
| All Invasive Malignant Tumors | 336.0 | 651.2 | 32.5 | 309.2 | 393.4 | 19.8 | 97.6 | 208.5 | 19.4 | 123.0 | 157.1 | 12.6 |
| Oral cavity and pharynx | 7.0 | 12.2 | 4.1 | 3.8 | 4.6 | 2.1 | 1.6 | 3.0 | 2.1 | 1.2 | 1.3 | 1.0 |
| Esophagus | 4.4 | 8.9 | 4.0 | 1.2 | 1.4 | 1.1 | 4.4 | 8.4 | 3.7 | 2.0 | 2.5 | 1.6 |
| Stomach | 6.8 | 15.8 | 5.6 | 8.2 | 10.1 | 3.1 | 3.6 | 9.1 | 4.4 | 4.8 | 5.8 | 2.4 |
| Colorectal | 30.8 | 63.2 | 10.5 | 32.0 | 41.1 | 6.4 | 11.2 | 23.0 | 6.4 | 11.2 | 13.7 | 3.6 |
| Colon excluding rectum | 24.0 | 49.2 | 9.2 | 24.6 | 31.8 | 5.7 | 9.6 | 19.8 | 5.9 | 9.8 | 12.0 | 3.4 |
| Rectum & rectosigmoid | 6.8 | 14.0 | 4.9 | 7.4 | 9.3 | 3.0 | 1.6 | 3.2 | 2.4 | 1.4 | 1.7 | 1.3 |
| Liver / intrahepatic bile duct | 10.6 | 18.5 | 5.1 | 2.4 | 3.0 | 1.7 | 6.8 | 13.2 | 4.6 | 3.0 | 4.0 | 2.1 |
| Pancreas | 8.6 | 16.5 | 5.1 | 8.0 | 9.7 | 3.0 | 6.0 | 11.2 | 4.1 | 6.6 | 8.3 | 2.9 |
| Larynx | 6.4 | 13.1 | 4.8 | 1.2 | 1.5 | 1.2 | 0.4 | 0.6 | 0.9 | 0.2 | 0.2 | 0.4 |
| Lung and bronchus | 37.6 | 75.5 | 11.3 | 34.2 | 44.5 | 6.7 | 23.4 | 50.1 | 9.5 | 26.4 | 34.1 | 5.9 |
| Melanoma of the skin | 0.8 | 1.5 | 1.4 | 0.8 | 1.1 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Female breast | 91.4 | 115.9 | 10.7 | 21.4 | 27.1 | 5.2 | ||||||
| Cervix uteri | 8.4 | 11.3 | 3.4 | 4.2 | 5.3 | 2.3 | ||||||
| Corpus uterus and NOS | 22.8 | 28.1 | 5.2 | 8.0 | 10.5 | 3.3 | ||||||
| Ovary | 8.8 | 11.3 | 3.4 | 5.0 | 6.5 | 2.6 | ||||||
| Prostate | 135.0 | 256.3 | 20.2 | 14.2 | 37.0 | 8.9 | ||||||
| Testis | 1.4 | 2.3 | 1.7 | 0.2 | 0.4 | 0.8 | ||||||
| Urinary bladder (incl. in situ) | 9.0 | 19.8 | 6.0 | 6.4 | 8.2 | 2.9 | 1.8 | 3.8 | 2.5 | 2.6 | 3.4 | 1.8 |
| Kidney and renal pelvis | 11.8 | 21.5 | 5.7 | 8.4 | 10.8 | 3.3 | 1.6 | 3.4 | 2.5 | 1.8 | 2.2 | 1.4 |
| Brain and other nervous system | 3.4 | 5.9 | 2.9 | 1.4 | 1.8 | 1.3 | 1.4 | 2.8 | 2.1 | 1.0 | 1.4 | 1.2 |
| Thyroid | 2.8 | 5.1 | 2.7 | 10.0 | 12.9 | 3.6 | 0.6 | 0.9 | 1.0 | 0.6 | 0.6 | 0.7 |
| Hodgkin lymphoma | 2.8 | 4.5 | 2.4 | 1.4 | 1.9 | 1.4 | 0.2 | 0.3 | 0.6 | 0.0 | 0.0 | 0.0 |
| Non-Hodgkin lymphomas | 12.0 | 22.5 | 5.9 | 10.0 | 12.9 | 3.6 | 2.6 | 5.2 | 3.0 | 2.6 | 3.6 | 2.0 |
| Myeloma | 9.6 | 18.9 | 5.6 | 12.2 | 15.7 | 4.0 | 4.4 | 9.2 | 4.0 | 4.6 | 6.1 | 2.5 |
| Leukemias | 8.2 | 15.5 | 4.9 | 7.2 | 9.3 | 3.1 | 4.0 | 8.4 | 3.8 | 3.4 | 4.1 | 2.0 |
Notes
- Incidence data are provisional, November 2012.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.
